William Duke, Jr
2020
In 2020, William Duke, Jr earned a total compensation of $1.2M as Chief Financial Officer principal financial officer at Kaleido Biosciences, a 30% decrease compared to previous year.
Compensation breakdown
| Bonus | $100,000 |
|---|---|
| Non-Equity Incentive Plan | $142,800 |
| Option Awards | $527,067 |
| Salary | $420,000 |
| Other | $10,069 |
| Total | $1,199,936 |
Duke received $527.1K in option awards, accounting for 44% of the total pay in 2020.
Duke also received $100K in bonus, $142.8K in non-equity incentive plan, $420K in salary and $10.1K in other compensation.
Rankings
In 2020, William Duke, Jr's compensation ranked 7,836th out of 13,090 executives tracked by ExecPay. In other words, Duke earned more than 40.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,836 out of 13,090 | 40th |
Division Manufacturing | 3,312 out of 5,624 | 41st |
Major group Chemicals And Allied Products | 1,344 out of 2,257 | 41st |
Industry group Drugs | 1,167 out of 1,957 | 40th |
Industry Biological Products, Except Diagnostic Substances | 274 out of 411 | 33rd |
Source: SEC filing on May 5, 2021.
Duke's colleagues
We found three more compensation records of executives who worked with William Duke, Jr at Kaleido Biosciences in 2020.